Organic sodium salts
Sigma Aldrich Fine Chemicals Biosciences CNQX disodium salt hydrate >=98% (HPLC), solid | 115066-14-3 (free base) | MFCD09953908 | 25MG
CNQX disodium salt hydrate >=98% (HPLC), solid | Purity: >=98% (HPLC) | 115066-14-3 (free base) | MFCD09953908 | 25MG
Chem-Impex International, Inc. Sodium tert-butoxide | MFCD00040575 | 25G
Sodium tert-butoxide, MFCD00040575, 25G
eMolecules Ferrozine mono-sodium salt hydrate | 63451-29-6 | 1G | Purity: 95%
Combi-Blocks | Ferrozine mono-sodium salt hydrate | 1G | 63451-29-6 | MFCD00150794
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 5 MG
NBQX disodium is a highly selective and competitive AMPA receptor antagonist. It exhibits neuroprotective and anticonvulsant activity by targeting AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex. It has demonstrated efficacy in decreasing PTZ-induced seizures and neuroprotection in focal ischemia models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Minimal affinity for the glutamate recognition site on the NMDA receptor complex
- Decreases seizures induced by PTZ
- Neuroprotective in focal ischemia models
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 1 ML
NBQX disodium is a highly selective and competitive AMPA receptor antagonist, known for its neuroprotective and anticonvulsant activities. It displays high affinity for AMPA and kainate binding sites.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Demonstrates anticonvulsant activity
- Targets AMPA receptors
- Decreases seizures induced by PTZ in animal models
- Neuroprotective in focal ischaemia models
Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 200 MG
DNQX (FG 9041) is a quinoxaline derivative and a selective, potent competitive non-NMDA glutamate receptor antagonist. It is characterized by its activity against various glutamate receptors.
- Selective, potent competitive non-NMDA glutamate receptor antagonist
- Targets AMPA receptors with an IC50 of 0.5 μM
- Targets kainate receptors with an IC50 of 2 μM
- Targets NMDA receptors with an IC50 of 40 μM
- Selectively depolarizes thalamic reticular nucleus (TRN) neurons in vitro
- Diminishes phencyclidine (PCP) induced hsp70 induction in vivo
Medchemexpress LLC DNQX | 2379-57-9 | C8H4N4O6 | 50 MG
DNQX (FG 9041) is a quinoxaline derivative that acts as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5 μM for AMPA receptors, 2 μM for kainate receptors, and 40 μM for NMDA receptors.
- Selective non-NMDA glutamate receptor antagonist
- Potent competitive antagonist
- IC50s: 0.5 μM (AMPA), 2 μM (kainate), 40 μM (NMDA)
- High purity (99.67%)
- Available as solid and solution
- In vivo dissolution protocols provided
- In vitro, depolarizes thalamic reticular nucleus (TRN) neurons
- In vivo, diminishes phencyclidine (PCP) hsp70 induction